Daniel H. Fowler, MD, discusses the challenges of graph-versus-host-disease (GVHD) in patients with high-risk lymphoma.
Daniel H. Fowler, MD, senior investigator, Center for Cancer Research, National Cancer Institute, discusses the challenges of graph-versus-host-disease (GVHD) in patients with high-risk lymphoma.
The most common problem when trying to cure lymphoma with a transplant is the lack of ability to control the disease, Fowler says. High-risk lymphoma types, such as diffuse large-cell lymphoma, transformed lymphoma, T cell lymphoma, and Hodgkin’s lymphoma, are more difficult to cure with a transplant when compared to other lymphoma types.
Fowler says another problem is that older patients do not handle the transplant well. Unfortunately, the median age of transplant patients with lymphoma is over 50 years old. Fowler says doctors have responded to this issue by reducing the amount of chemotherapy and radiation prior to the transplant, in order to get better results.
Another important aspect in the lymphoma transplant field is the patient’s disease state, Fowler says. Patients in complete remission or partial remission respond better than patients whose lymphoma is not responding to chemotherapy.
Fowler says half of his lymphoma patients are in the category of not responding to chemotherapy, but in clinical trials, these patients are seeing some favorable results.
Examining the Non-Hodgkin Lymphoma Treatment Paradigm
July 15th 2022In season 3, episode 6 of Targeted Talks, Yazan Samhouri, MD, discusses the exciting new agents for the treatment of non-Hodgkin lymphoma, the clinical trials that support their use, and hopes for the future of treatment.
Listen